Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2.675 USD | -0.56% | -2.92% | -34.97% |
13/05 | Morgan Stanley Lowers Price Target on Organogenesis Holdings to $3 From $3.50, Keeps Equalweight Rating | MT |
10/05 | Health Care Edges Higher Amid Rotation to Utilities - Health Care Roundup | DJ |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-34.97% | 36Cr | |
+69.10% | 6.29TCr | |
-0.98% | 4.14TCr | |
+45.66% | 4.04TCr | |
-10.72% | 2.76TCr | |
+14.12% | 2.65TCr | |
-21.97% | 1.89TCr | |
+4.32% | 1.27TCr | |
+24.02% | 1.23TCr | |
+28.51% | 1.21TCr |
- Stock Market
- Equities
- ORGO Stock
- News Organogenesis Holdings Inc.
- Transcript : Organogenesis Holdings Inc., Q1 2022 Earnings Call, May 10, 2022